111 filings
10-Q
2024 Q1
GRTX
Galera Therapeutics Inc
Quarterly report
13 May 24
7:30am
8-K
GRTX
Galera Therapeutics Inc
13 May 24
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
7:05am
8-K
GRTX
Galera Therapeutics Inc
3 May 24
Galera Adopts Limited Duration Stockholder Rights Agreement
4:24pm
8-A12B
GRTX
Galera Therapeutics Inc
3 May 24
Registration of securities on exchange
4:07pm
10-K
2023 FY
GRTX
Galera Therapeutics Inc
Annual report
28 Mar 24
7:30am
8-K
k2yizc
28 Mar 24
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
7:06am
8-K
r322ea01q 18uhr
27 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:31am
8-K
i55dh6zl
14 Nov 23
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
12:00am
8-K
cxtzptaa
31 Oct 23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
7:10am
8-K
u57jp8rc
26 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:24am
8-K
7v90guyh z1nbrrjui
22 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:12pm
8-K
ckww29ehbocksxx4
14 Aug 23
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
7:10am
8-K
e0c5nk
10 Aug 23
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
8:00am
8-K
2bqs4q3rdz5qvn bb
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
dv6d41k q5
30 May 23
Other Events
8:51am
S-8
n8jydbkbt
11 May 23
Registration of securities for employees
4:06pm
8-K
q10n5
11 May 23
Galera Reports First Quarter 2023 Financial Results and Recent Corporate
7:11am